Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd. on November 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.05 CNY | -2.70% | -5.79% | -49.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.19% | 10.54B | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-10.30% | 34.47B | |
+64.64% | 26.7B | |
-15.93% | 15.13B | |
-6.99% | 13.27B | |
-11.77% | 11.74B | |
+8.09% | 9.41B | |
+141.62% | 9.22B |
- Stock Market
- Equities
- 300122 Stock
- News Chongqing Zhifei Biological Products Co., Ltd.
- Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.